Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
Read More
Pulmatrix and Eos merge to advance gerotherapeutics
Read More
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan PRN Newswire Release • Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology...
Read More
